Prostate cancer screening with prostate-specific antigen: A guide to the guidelines

BACKGROUND: Prostate cancer remains the most common non-skin cancer malignancy in men. Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring, and risk prediction of prostate cancer. Its use in the setting of prostate cancer screening has been controversial due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabarkapa, Sonja, Perera, Marlon, McGrath, Shannon, Lawrentschuk, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153437/
https://www.ncbi.nlm.nih.gov/pubmed/27995110
http://dx.doi.org/10.1016/j.prnil.2016.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153437/
https://www.ncbi.nlm.nih.gov/pubmed/27995110
http://dx.doi.org/10.1016/j.prnil.2016.09.002

Ejemplares similares